A Study of the Safety and Tolerability in Participants With PIK3CA-related Overgrowth Spectrum or Proteus Syndrome Who Are Being Treated With Miransertib (MK-7075) in Other Studies (MK-7075-006)
PHASE2
This is a study of the safety and tolerability of oral miransertib (MK-7075...
Status
Active Not Recruiting
Location
Children's Healthcare of Atlanta - Egleston Hospital ( Site 0107)